EPIQ Series Diagnostic Ultrasound System vs Analytic for Hemodynamic Instability (AHI)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

EPIQ Series Diagnostic Ultrasound System

by Philips

Analytic for Hemodynamic Instability (AHI)

by Fifth Eye Inc.

AI Verdict

Tool A is a diagnostic ultrasound system leveraging AI for enhanced imaging and workflow across various specialties, including cardiology. In contrast, Tool B is an AI-driven clinical decision support software focused on predicting hemodynamic instability in critical care settings using continuous patient monitoring data. While both utilize AI in cardiology and emergency medicine, Tool A is for diagnostic imaging, whereas Tool B provides predictive analytics for patient deterioration.

Choose EPIQ Series Diagnostic Ultrasound System if…

Choose the Philips EPIQ Series Diagnostic Ultrasound System if your facility requires a comprehensive, premium ultrasound solution for advanced diagnostic imaging across multiple specialties. This system is ideal for departments needing AI-powered insights and sophisticated workflow tools to enhance diagnostic confidence in areas like cardiology, obstetrics/gynecology, and radiology, where detailed anatomical and functional assessments are critical.

View EPIQ Series Diagnostic Ultrasound System →

Choose Analytic for Hemodynamic Instability (AHI) if…

Choose Fifth Eye's Analytic for Hemodynamic Instability (AHI) if your hospital needs an AI-driven clinical decision support system for continuous, real-time monitoring of adult in-hospital patients at risk of hemodynamic instability. This tool is best suited for critical care and emergency settings where early prediction of deterioration, hours before traditional vital signs change, is essential for proactive intervention and improved patient outcomes.

View Analytic for Hemodynamic Instability (AHI) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	EPIQ Series Diagnostic Ultrasound System	Analytic for Hemodynamic Instability (AHI)
Deployment	Unknown	Integrates with existing hospital ECGs and can be deployed through platforms like Medical Informatics Corp.'s Sickbay™ and VitalConnect's remote patient monitoring solution.
FDA Status	Unknown	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Analytic for Hemodynamic Instability (AHI)

Tool B emphasizes ease of interpretation with 'easy-to-interpret visual indicators (red, yellow, green)' and accessibility via 'any browser-enabled device,' directly reducing nurse surveillance burden. While Tool A offers 'advanced workflow solutions' and 'SmartExam' for imaging, Tool B's design appears more universally intuitive for immediate clinical decision support across a broader user base.

Clinical Value

Analytic for Hemodynamic Instability (AHI)

Tool B provides a critical early warning system for hemodynamic instability, predicting issues 'hours ahead of traditional vital signs' and potentially enabling proactive, life-saving interventions. While Tool A enhances diagnostic confidence in imaging, Tool B's direct impact on preventing adverse patient events through early prediction offers a distinct and potentially higher clinical value in critical care scenarios.

Pricing & Value

EPIQ Series Diagnostic Ultrasound System

Tool A offers more transparency regarding its pricing, providing a range for refurbished units and noting new systems are enterprise-level and negotiated. Tool B's pricing is 'not specified' and requires contacting the vendor, making it difficult to assess its value proposition without any cost information.

Enterprise Readiness

EPIQ Series Diagnostic Ultrasound System

Tool A, as a product from Philips, a global leader in medical technology, has a long-standing history of enterprise deployment across 'Solo to large health systems' and explicitly states HIPAA compliance. While Tool B is an FDA-cleared SaMD designed for integration, its HIPAA compliance and BAA are listed as 'likely, contact vendor for details,' indicating a slightly less definitive stance compared to Tool A's established presence.

Innovation

Analytic for Hemodynamic Instability (AHI)

Tool B demonstrates higher innovation by offering a novel AI-driven predictive capability for hemodynamic instability, providing early warnings up to 26 hours ahead of traditional vital signs. This represents a significant shift from reactive to proactive patient care. While Tool A incorporates AI for enhanced imaging and automated measurements, Tool B's predictive analytics fundamentally changes the approach to monitoring a critical physiological state.

Support & Docs

EPIQ Series Diagnostic Ultrasound System

Philips, as a large, established global company, is expected to offer extensive and robust support, training, and documentation for its complex medical devices like the EPIQ Series. While Fifth Eye provides dedicated clinical and technical support, Philips' global reach and comprehensive infrastructure likely provide a more extensive and readily available support ecosystem.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	EPIQ Series Diagnostic Ultrasound System	Analytic for Hemodynamic Instability (AHI)
Product Name	EPIQ Series Diagnostic Ultrasound System	Analytic for Hemodynamic Instability (AHI)
Company	Philips Ultrasound	Fifth Eye
Primary Function	Premium AI-powered imaging and advanced workflow solutions for enhanced diagnostic confidence across diverse clinical applications.	AI-driven clinical decision support software that continuously monitors adult in-hospital patients for signs of hemodynamic instability, providing early warnings.
Target User/Application Focus	Solo to large health systems (Diagnostic Ultrasound)	Adult in-hospital patients for signs of hemodynamic instability (Clinical Decision Support)
Categories	Cardiology AI, OB/GYN AI, Radiology & Imaging AI	Cardiology AI, Triage & ER/ICU AI
Key Technologies/Features	nSIGHT Imaging Architecture, PureWave Crystal Technology, xMATRIX Transducer Technology, Anatomical Intelligence Ultrasound (AIUS)	Predicts hemodynamic instability earlier than vital signs (up to 26 hours for AHI-PI), Uses continuous ECG lead II data for analysis

Videos

Demos, reviews, and walkthroughs featuring EPIQ Series Diagnostic Ultrasound System and Analytic for Hemodynamic Instability (AHI).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools specifically integrate into and enhance existing clinical workflows for physicians?

The Philips EPIQ system aims to enhance diagnostic confidence through premium AI-powered imaging and smarter workflows, streamlining the imaging process across diverse clinical applications. Fifth Eye's AHI system provides early warnings for hemodynamic instability, reducing nurse surveillance burden and streamlining workflow for proactive patient care.

What is the depth of EHR integration for each tool, and how does it support a seamless clinical experience?

The Philips EPIQ system offers data export capabilities, allowing for the transfer of diagnostic information. Fifth Eye's AHI system integrates with existing in-hospital monitoring platforms and is accessible via any browser-enabled device, suggesting a more embedded integration within the patient monitoring ecosystem.

What is the expected learning curve for physicians and clinical staff to effectively utilize each system's advanced features?

While not explicitly stated, the Philips EPIQ system features like SmartExam and Real Time iSCAN (Autoscan) are designed to offer smarter workflows, potentially simplifying complex imaging tasks. Fifth Eye's AHI system utilizes easy-to-interpret visual indicators (red, yellow, green) to present its AI-driven insights, suggesting a relatively low learning curve for interpreting patient status.

For which clinical specialties and scenarios are these tools most beneficial, and how do their AI capabilities directly aid clinical decision-making?

The Philips EPIQ system is beneficial across a broad range of specialties including Cardiology, OB/GYN, and Radiology, utilizing AI for enhanced imaging and automated measurements to improve diagnostic confidence. Fifth Eye's AHI system is tailored for Cardiology, Critical Care, and Emergency Medicine, providing AI-driven early warnings of hemodynamic instability to enable proactive patient care.

How do the AI capabilities of each tool contribute to diagnostic accuracy or provide predictive clinical insights?

The Philips EPIQ system leverages AI-powered imaging and Anatomical Intelligence Ultrasound (AIUS) to enhance diagnostic confidence and provide AI-enhanced imaging and automated measurements. Fifth Eye's AHI system uses AI and machine learning to predict hemodynamic instability earlier than traditional vital signs, offering early warnings up to 26 hours ahead for proactive intervention.

What are the key considerations for implementing and scaling these tools across multiple hospital sites or a large health system?

The Philips EPIQ system is an on-premise diagnostic ultrasound system targeting solo practices to large health systems, implying hardware deployment and integration at each site. Fifth Eye's AHI system, as a Software as a Medical Device (SaMD), integrates into existing in-hospital monitoring platforms and is accessible via any browser-enabled device, potentially simplifying multi-site deployment through software integration.